Amid signs of de-escalating Middle East tensions and strong earnings reports, global markets have shown resilience, with major indexes like the Nasdaq Composite and S&P 500 reaching record highs. In this environment of optimism, dividend stocks can offer a compelling investment opportunity by providing regular income streams alongside potential capital appreciation.
|
Name |
Dividend Yield |
Dividend Rating |
|
Yeni Gimat Gayrimenkul Yatirim Ortakligi (IBSE:YGGYO) |
3.10% |
★★★★★★ |
|
Toukei Computer (TSE:4746) |
3.87% |
★★★★★★ |
|
Telekom Austria (WBAG:TKA) |
4.29% |
★★★★★★ |
|
Swiss Re (SWX:SREN) |
4.80% |
★★★★★★ |
|
NCD (TSE:4783) |
4.59% |
★★★★★★ |
|
Guangxi LiuYao Group (SHSE:603368) |
4.48% |
★★★★★★ |
|
GakkyushaLtd (TSE:9769) |
4.57% |
★★★★★★ |
|
CREEK & RIVER (TSE:4763) |
3.70% |
★★★★★★ |
|
Binggrae (KOSE:A005180) |
4.40% |
★★★★★★ |
|
Banque Cantonale Vaudoise (SWX:BCVN) |
3.59% |
★★★★★★ |
Click here to see the full list of 500 stocks from our Top Global Dividend Stocks screener.
Let’s take a closer look at a couple of our picks from the screened companies.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Bank of Nanjing Co., Ltd. offers a range of financial products and services in China, with a market cap of CN¥142.30 billion.
Operations: Bank of Nanjing Co., Ltd. generates revenue through its diverse financial offerings within China.
Dividend Yield: 4.3%
Bank of Nanjing’s dividend yield is among the top 25% in the Chinese market, at 4.29%. Despite a volatile dividend history with significant annual drops, recent earnings growth of CNY 6.60 billion suggests improved financial health. The current payout ratio is a low 28.1%, indicating dividends are well covered by earnings and expected to remain sustainable over the next three years, with forecasted annual earnings growth of 8.49%.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Yifeng Pharmacy Chain Co., Ltd. operates in the retail business of pharmaceutical products in China, with a market cap of CN¥28.39 billion.
Operations: Yifeng Pharmacy Chain Co., Ltd. generates revenue primarily from its pharmaceutical retail operations in China.
Dividend Yield: 3.2%
Yifeng Pharmacy Chain’s dividend yield of 3.24% ranks in the top 25% of Chinese market payers, supported by a reasonable payout ratio of 51.9%, ensuring coverage by earnings. The cash payout ratio stands at a low 32.1%, indicating strong cash flow support for dividends despite an unstable and volatile dividend history over the past decade. Recent earnings growth to CNY 1,678.48 million further strengthens its capacity to maintain dividend payments.